NASDAQ:IMI - Intermolecular SEC Filings & 10K Form

$1.19
0.00 (0.00 %)
(As of 08/21/2019 04:00 PM ET)
Today's Range
$1.18
Now: $1.19
$1.19
50-Day Range
$1.16
MA: $1.17
$1.19
52-Week Range
$0.88
Now: $1.19
$1.42
Volume7,900 shs
Average Volume289,384 shs
Market Capitalization$59.21 million
P/E RatioN/A
Dividend YieldN/A
Beta0.94

SEC Filings

Intermolecular (NASDAQ:IMI) SEC Filings

DateFilerForm TypeView
08/14/2019
5:13 AM
Intermolecular (Subject)
Merck KGaA (Filed by)
Form SC 13D/A
View Filing
08/08/2019
3:19 PM
Intermolecular (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/08/2019
3:15 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/17/2019
3:27 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/28/2019
6:05 AM
Intermolecular (Filer)
Form DEFA14A
View Filing
06/12/2019
7:30 AM
Intermolecular (Filer)
Form DEFM14A
View Filing
05/28/2019
4:13 PM
Intermolecular (Filer)
Form PREM14A
View Filing
05/16/2019
3:15 PM
Intermolecular (Subject)
Merck KGaA (Filed by)
Form SC 13D
View Filing
05/14/2019
3:21 PM
Intermolecular (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/08/2019
8:13 PM
Intermolecular (Issuer)
Redpoint Associates II, LLC (Reporting)
Redpoint Ventures II, L.P. (Reporting)
Redpoint Ventures II, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/07/2019
3:58 PM
Intermolecular (Subject)
Raging Capital Management, LLC (Filed by)
Form SC 13D/A
View Filing
05/06/2019
10:59 AM
Intermolecular (Subject)
Merck KGaA (Filed by)
Form DFAN14A
View Filing
05/06/2019
8:16 AM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/06/2019
8:15 AM
Intermolecular (Filer)
Form DEFA14A
View Filing
04/29/2019
4:28 PM
Intermolecular (Filer)
Form 10-K/A
View Filing
04/03/2019
2:32 PM
Intermolecular (Subject)
SUBIN NEIL S (Filed by)
Form SC 13G/A
View Filing
04/02/2019
4:21 PM
Intermolecular (Subject)
Raging Capital Management, LLC (Filed by)
Form SC 13D/A
View Filing
03/08/2019
3:21 PM
Intermolecular (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/04/2019
6:59 PM
Intermolecular (Issuer)
Redpoint Associates II, LLC (Reporting)
Redpoint Ventures II, L.P. (Reporting)
Redpoint Ventures II, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/25/2019
9:38 AM
Intermolecular (Issuer)
SUBIN NEIL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/21/2019
3:41 PM
Intermolecular (Issuer)
SUBIN NEIL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2019
3:15 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/01/2019
1:20 PM
Intermolecular (Subject)
Presidio Partners 2014, L.P. (Filed by)
Form SC 13G/A
View Filing
12/28/2018
3:07 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
4:18 PM
Intermolecular (Issuer)
KRAUSZ STEVEN M (Reporting)
LIDDLE DAVID E (Reporting)
Matteucci Paul A (Reporting)
Presidio Management Group IX, L.L.C. (Reporting)
ROOT JONATHAN D (Reporting)
Tansey Casey M (Reporting)
U S Venture Partners IX L P (Reporting)
YOUNG PHILIP M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/13/2018
4:17 PM
FEDERMAN IRWIN (Reporting)
Intermolecular (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/06/2018
3:15 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/16/2018
6:18 PM
Intermolecular (Issuer)
ROESCHLEIN BILL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/16/2018
6:15 PM
Intermolecular (Issuer)
Kramer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/06/2018
3:15 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/29/2018
5:13 PM
Intermolecular (Issuer)
Scheer Adam Louis Abraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
5:12 PM
Intermolecular (Issuer)
TRAUB KENNETH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
5:11 PM
BURKETT MARVIN D (Reporting)
Intermolecular (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
5:11 PM
FEDERMAN IRWIN (Reporting)
Intermolecular (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
5:10 PM
Intermolecular (Issuer)
SCALISE GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
5:09 PM
Furnas Matthew (Reporting)
Intermolecular (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
5:08 PM
Intermolecular (Issuer)
Schultz Jonathan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:15 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/11/2018
3:15 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2018
3:16 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2018
3:12 PM
Intermolecular (Filer)
Form DEFA14A
View Filing
04/10/2018
3:10 PM
Intermolecular (Filer)
Form DEF 14A
View Filing
03/08/2018
4:27 PM
Intermolecular (Issuer)
ROESCHLEIN BILL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/20/2018
7:24 PM
Intermolecular (Issuer)
ROESCHLEIN BILL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
7:13 PM
Intermolecular (Issuer)
Kramer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/20/2018
2:29 PM
Intermolecular (Issuer)
Schultz Jonathan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/16/2018
5:48 PM
Intermolecular (Issuer)
Scheer Adam Louis Abraham (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/13/2018
3:18 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/12/2018
3:08 PM
Intermolecular (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/12/2018
10:27 AM
Intermolecular (Subject)
Presidio Partners 2014, L.P. (Filed by)
Form SC 13G/A
View Filing
01/31/2018
2:02 PM
Intermolecular (Subject)
U S Venture Partners IX L P (Filed by)
Form SC 13G/A
View Filing
01/23/2018
2:25 PM
Intermolecular (Subject)
SUBIN NEIL S (Filed by)
Form SC 13G
View Filing
01/22/2018
1:03 PM
Intermolecular (Issuer)
SUBIN NEIL S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
This page was last updated on 8/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel